Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Axsome Therapeutics Ord Shs
(NQ:
AXSM
)
78.61
USD
-1.15 (-1.44%)
Streaming Delayed Price
/ Updated:
3:40 PM EDT, Aug 14, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
199,870
Open
79.68
Bid (Size)
78.57 (2)
Ask (Size)
78.65 (1)
Prev. Close
79.76
Today's Range
78.59 - 81.05
52wk Range
13.64 - 109.94
Shares Outstanding
25,685,492
Dividend Yield
N/A
Performance
YTD
-22.41%
-22.41%
1 Month
-1.02%
-1.02%
3 Month
-5.86%
-5.86%
6 Month
-11.35%
-11.35%
1 Year
+195.42%
+195.42%
Top News
More News
Axsome Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update
August 10, 2020
from
GlobeNewswire News Releases
Axsome Therapeutics Announces Further Progress in AXS-05 Depression Clinical Program
August 10, 2020
from
GlobeNewswire News Releases
More News
Read More
Axsome Therapeutics Receives FDA Breakthrough Therapy Designation for AXS-12 for the Treatment of Narcolepsy
August 05, 2020
from
GlobeNewswire News Releases
Axsome Therapeutics to Report Second Quarter 2020 Financial Results on August 10, 2020
July 30, 2020
from
GlobeNewswire News Releases
Axsome Therapeutics Completes Successful FDA Pre-NDA Meeting for AXS-05 for the Treatment of Major Depressive Disorder
July 13, 2020
from
GlobeNewswire News Releases
Why Axsome Therapeutics Stock Rose Today
August 10, 2020
category
AXSM
,
Market News
from
Motley Fool
Implied VBR Analyst Target Price: $125
August 03, 2020
category
ETFs
from
ETF Channel
Axsome Therapeutics, Inc. (AXSM) Q2 2020 Earnings Call Transcript
August 10, 2020
category
AXSM
,
Market News
from
Motley Fool
Noteworthy Friday Option Activity: AXSM, ESPR, OPK
July 31, 2020
category
Stocks
from
Market News Video
Bag This Bargain Even Cheaper Than Chief Financial Officer Pizzie Did
July 14, 2020
category
Stocks
from
Market News Video
Notable Wednesday Option Activity: WBA, URBN, AXSM
July 08, 2020
category
Stocks
from
Market News Video
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
